Read + Share
Ushida Y, Inoue Y, Ito H, Oba A, et al. High CA19-9 level in resectable pancreatic cancer is a potential indication of
neoadjuvant treatment. Pancreatology 2020 Dec 4. pii: S1424-3903(20)30859.
PMID: 33303373
|
 |
|
Ushida Y, Inoue Y, Ito H, Oba A, et al. High CA19-9 level in resectable pancreatic cancer is a potential indication of
neoadjuvant treatment. Pancreatology 2020 Dec 4. pii: S1424-3903(20)30859.
PMID: 33303373
|
|
|
|